Glycerol phenylbutyrate reduces hepatic encephalopathy events in cirrhosis

Glycerol phenylbutyrate significantly reduced the number of cirrhosis patients experiencing hepatic encephalopathy and the time to first event, a phase II trial has shown.

The randomized,...